Global Temperature Controlled Pharma Packaging Solutions Market, By Product (Insulated Shippers, Insulated Containers, Others), Type (Active Systems, Passive Systems), Temperature Range (Up to 10°C, 10°C to 20°C, More than 20°C), Payload Capacity (Up to 10 L, 10-20 L, 20-40 L, 40-150 L, More than 150 L), Usability (Single Use, Reusable), Application (Frozen, Chilled, Ambient), End User (Pharmaceutical, Clinical Trial) – Industry Trends and Forecast to 2029
Market Analysis and Size
Biopharma products or Biopharmaceuticals are known to be as a derivative of biological sources such as an animal, microorganisms and humans. Gene therapies, and others like cell therapies, Vaccines, enzymes, tissues, are some examples of biopharmaceuticals. These products are part of the pharmaceutical market's temperature-controlled packaging. These packaging are susceptible to humidity and heat and, hence, need to be stored in low temperatures for storage and shipping.
Data Bridge Market Research analyses that the temperature controlled pharma packaging solutions market was valued at USD 39.50 billion in 2021 and is expected to reach USD 68.63 billion by 2029, registering a CAGR of 7.15 % during the forecast period of 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, import/export analysis, pricing analysis, production consumption analysis, patent analysis and technological advancements.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Insulated Shippers, Insulated Containers, Others), Type (Active Systems, Passive Systems), Temperature Range (Up to 10°C, 10°C to 20°C, More than 20°C), Payload Capacity (Up to 10 L, 10-20 L, 20-40 L, 40-150 L, More than 150 L), Usability (Single Use, Reusable), Application (Frozen, Chilled, Ambient), End User (Pharmaceutical, Clinical Trial)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Sonoco Products Company (U.S.), Cold Chain Technologies (U.S.), Va-Q-Tec AG (Germany), Pelican BioThermal Limited (U.S.), Softbox (U.K.), Sofrigam SA (France), Intelsius (U.K.), Inmark Global Holdings, LLC (U.S.), Envirotainer (Sweden), Fedex (U.S.), United Parcel Service of America, Inc (U.S.), Amerisourcebergen Corporation (U.S.), Snyder Industries (U.S.), ACH Foam Technologies, LLC (U.S.), Cryopak Industries Inc. (Canada), Saeplast (U.S.), Tempack (Spain), Exeltainer (Spain), OMEGA Engineering (U.S.), Olympus Corporation (Japan)
|
|
Market Opportunities
|
|
Market Definition
Temperature controlled pharma packaging (TCP) is a strong semi-rigid liner that delivers greater insulation than other bio foam and enhanced physical protection against environmental impact. During the production of temperature controlled packaging solutions used cold chain process. The cold chain is thus more than a process of tasks which must be performed to monitor temperature, transport, prepare and store sensitive products. It is also a science that requires understanding the chemical and biological concepts that determine perishability. Together, cold chain is also a technology which uses combinations of specialized equipment and physical means to ensure the suitable temperature conditions along the supply chain.
Temperature Controlled Pharma Packaging Solutions Market Dynamics
Drivers
- Maintaining quality and provide safety
Temperature-controlled pharma packaging solution is an imperious tool used to reduce the upholding quality of product and hazard during the process of supply chain by maintaining internal temperature in pharma sector. This system supports to protect the shipments through every stage of the medical supply chain. Some of the main application areas of temperature-controlled packaging solutions in which included medical products with detailed timeline and pharma products, vaccines, biological samples, clinical trials and inactive pharmaceutical ingredients with balanced temperature requirements due to these factors increase the demand of temperature controlled pharma packaging solutions and expected to drive the market growth rate.
- Rising demand due to maintain hygiene and for thermal obligation
The U.S. Food and Drug Administration has computed thermal requirements for storing, handling and transporting the drugs. These containers address thermal obligation and the hygiene of the healthcare products like organs, vaccines, drugs and blood. Over the past couple of years, international health organizations such as the World Health Organization (WHO) have been emphasizing the dropping of vaccine waste. Also, increasing initiatives to monitor vaccine wastage are expected to boost the demand for the temperature controlled pharma packaging solutions in the market.
Opportunities
Increasing the concentration of pharmaceutical producers on manufacturing drugs and therapies for the rare disease which is projected to create profitable growth opportunities for the temperature controlled packaging solutions market. The major market players in the pharmaceutical industry are capitalizing immensely on the research and development of vaccines for rare diseases including blood diseases. Increasing support and rising government initiatives are boosting the companies to develop orphan drugs for the rare diseases globally. Furthermore, upsurge in the emerging new markets and new strategic collaborations will also act as market drivers, further increasing the useful opportunities for the temperature-controlled pharma packaging solutions market growth.
Restraints/ Challenges
However, Lack of understanding of the profits of temperature-controlled pharmaceutical packaging solutions due to the presence of only few companies in the industry which are using temperature-controlled pharmaceutical packaging solutions are anticipated to obstruct the temperature controlled pharma packaging solutions market growth during forecast period. Furthermore, stringent government rules associated with the use of specific types of pharmaceutical products for the production of temperature-controlled packaging solution is the major factor expected to hamper the growth rate of the global temperature-controlled packaging solutions market.
This temperature controlled pharma packaging solutions market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the temperature controlled pharma packaging solutions market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Temperature Controlled Pharma Packaging Solutions Market
The outbreak of covid-19 pandemic has affected numerous industries but during this pandemic the temperature controlled packaging solutions market (TCP market) grew by 4% in terms of value. The demand of this packaging increased in market due to the distribution of the coronavirus vaccines overall the globe. The businesses advanced their packaging system for shipping vaccines, test kits and other critical medicines. The temperature-controlled packaging is susceptible to the product damage due to the temperature excursion. COVID-19 enhanced the trends in the temperature-controlled packaging solution market. The vaccine production company’s work together with the temperature-controlled packaging suppliers to develop which has modified the products for the delivery of vaccines.
Recent Development
- In November 2020, Cold Chain Technologies strategic to open a new facility in Lebanon which is in U.S. for the extensive distribution of COVID-19 vaccines.
- In February 2020, Pelican BioThermal LLC declared its acquisition with NanoCool LLC. This company is probable to be involved in the manufacture of temperature-controlled packaging systems.
Global Temperature Controlled Pharma Packaging Solutions Market Scope
The temperature controlled pharma packaging solutions market is segmented on the basis of products, type, temperature range, payload capacity, usability, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Insulated Shippers
- Panels and Envelopes
- EPS Foam Containers
- Fiberboards
- PUR Containers
- Insulated Containers
- Chest Style
- Upright Style
- Others
Type
- Active Systems
- Passive Systems
Temperature Range
- Up to 10°C
- 10°C to 20°C
- More than 20°C
Payload Capacity
- Up to 10 L
- 10-20 L
- 20-40 L
- 40-150 L
- More than 150 L
Usability
- Single Use
- Reusable
Application
- Frozen
- Chilled
- Ambient
End User
- Pharmaceutical
- Clinical Trial
Temperature Controlled Pharma Packaging Solutions Market Regional Analysis/Insights
The temperature controlled pharma packaging solutions market is analysed and market size insights and trends are provided by country, products, type, temperature range, payload capacity, usability, application and end-user as referenced above.
The countries covered in the temperature controlled pharma packaging solutions market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the temperature controlled pharma packaging solutions market in terms of revenue and market share during the forecast period. This is due to the increasing demand for temperature controlled pharma packaging solutions in this region. North America region leads the temperature controlled pharma packaging solutions market due to its augmented demand for temperature-controlled packaging in this region.
During the projected period, Europe is anticipated to be the fastest developing region due to growing healthcare sector and cloud computing in this region.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Temperature Controlled Pharma Packaging Solutions Market Share Analysis
The temperature controlled pharma packaging solutions market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to temperature controlled pharma packaging solutions market.
Some of the major players operating in the temperature controlled pharma packaging solutions market are:
- Sonoco Products Company (U.S.)
- Cold Chain Technologies (U.S.)
- Va-Q-Tec AG (Germany)
- Pelican BioThermal Limited (U.S.)
- Softbox (U.K.)
- Sofrigam SA (France)
- Intelsius (U.K.)
- Inmark Global Holdings, LLC (U.S.)
- Envirotainer (Sweden)
- Fedex (U.S.)
- United Parcel Service of America, Inc (U.S.)
- Amerisourcebergen Corporation (U.S.)
- Snyder Industries (U.S.)
- ACH Foam Technologies, LLC (U.S.)
- Cryopak Industries Inc. (Canada)
- Saeplast (U.S.)
- Tempack (Spain)
- Exeltainer (Spain)
- OMEGA Engineering (U.S.)
- Olympus Corporation (Japan)
SKU-